Phase II trial of gefitinib combined with docetaxel as first-line therapy in patients with metastatic breast cancer.

被引：0
|
作者：
Ciardiello, F
Troiani, T
Caputo, F
de Laurentiis, M
Tortora, G
Palmieri, G
de Vita, F
Colantuoni, G
de Placido, S
Bianco, AR
机构：
[1] Univ Naples 2, Naples, Italy
[2] Univ Naples Federico II, Naples, Italy
[3] SG Moscati Gen Hosp, Avellino, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：211S / 211S
页数：1
相关论文
共 50 条
  • [1] A Phase II study of gefitinib combined with docetaxel as first-line treatment in patients with advanced breast cancer.
    Ciardiello, F
    Troiani, T
    Caputo, F
    De Laurentiis, M
    Palmieri, G
    Marinelli, A
    Colantuoni, G
    Diadema, MR
    De Placido, S
    Bianco, AR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 58S - 58S
  • [2] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    Ciardiello, F.
    Troiani, T.
    Caputo, F.
    De Laurentiis, M.
    Tortora, G.
    Palmieri, G.
    De Vita, F.
    Diadema, M. R.
    Orditura, M.
    Colantuoni, G.
    Gridelli, C.
    Catalano, G.
    De Placido, S.
    Bianco, A. R.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1604 - 1609
  • [3] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    F Ciardiello
    T Troiani
    F Caputo
    M De Laurentiis
    G Tortora
    G Palmieri
    F De Vita
    M R Diadema
    M Orditura
    G Colantuoni
    C Gridelli
    G Catalano
    S De Placido
    A R Bianco
    [J]. British Journal of Cancer, 2006, 94 : 1604 - 1609
  • [4] A phase II study of bi-weekly docetaxel as first-line therapy for metastatic breast cancer.
    Durna, L. N.
    Yeon, C. H.
    Bosserman, L. D.
    Allison, M.
    Hu, E.
    Tchekmedyian, N. S.
    Srivastava, N.
    Ngo, D.
    Lin, L. S.
    Classen, S.
    Slamon, D. J.
    Pegram, M. D.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S280 - S280
  • [5] Gemcitabine as first-line therapy in patients with metastatic breast cancer: A phase II trial
    Blackstein, M
    Vogel, CL
    Ambinder, R
    Cowan, J
    Iglesias, J
    Melemed, A
    [J]. ONCOLOGY, 2002, 62 (01) : 2 - 8
  • [6] An phase II trial of docetaxel and cisplatin as first-line therapy for anthracycline-naive metastatic breast cancer patients
    Shen, Wen-Chi
    Chang, Hsien-Kun
    Chen, Jen-Shi
    Lin, Yung-Chang
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 86 - 86
  • [7] Phase II trial of weekly docetaxel/gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancer
    O'Shaughnessy, Joyce A.
    Pluenneke, Robert
    Sternberg, Jack
    Khandelwal, Pankaj
    Ilegbodu, Des
    Asmar, Lina
    [J]. CLINICAL BREAST CANCER, 2006, 6 (06) : 505 - 510
  • [8] Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial
    ten Tije, AJ
    Smorenburg, CH
    Seynaeve, C
    Sparrebooma, A
    Schothorst, KLC
    Kerkhofs, LGM
    van Reisen, LGPM
    Stoter, G
    Bontenbal, M
    Verweij, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) : 352 - 357
  • [9] Trastuzumab plus capecitabine and docetaxel as first-line therapy for metastatic breast cancer: Phase II results
    Gennatas, C. G.
    Michalaki, V.
    Gennatas, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] A phase II trial of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
    Meshref, M. M.
    Samir, S.
    Saad, E.
    Gouda, Y.
    Elmesidy, S.
    Koheil, H.
    Elzawahri, H.
    Kandil, A.
    Abdelhamid, T.
    Zaki, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345